Thrombopoietin promotes hematopoietic recovery and survival after high- dose whole body irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 4, 1999, Pages 867-875

  Mouthon, Marc André ^a   Van Der Meeren, Anne ^a   Gaugler, Marie Hélène ^a   Visser, Trudi P ^b   Squiban, Claire ^a   Gourmelon, Patrick ^a   Wagemaker, Gerard ^b  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Hematopoiesis; Ionizing radiation; Mice; Survival; Thrombopoietin

Indexed keywords

RECOMBINANT THROMBOPOIETIN;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW DEPRESSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ERYTHROPOIESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOPOIESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SURVIVAL; THROMBOCYTE FUNCTION; THROMBOCYTOPOIESIS; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ANIMALS; BLOOD CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; THROMBOPOIETIN; WHOLE-BODY IRRADIATION;

EID: 0033065969     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00477-5     Document Type: Article

References (73)

1. Monroy R.L., Skelly R.R., Taylor P., et al. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol. 16:1988;344-348.
2. Talmadge J.E., Tribble H., Pennington R., et al. Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors. Blood. 73:1989;2093-2103.
3. Ganser A., Lindemann A., Seipelt G., et al. Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood. 76:1990;666-676.
4. Patchen M.L., MacVittie T.J., Williams J.L., et al. Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood. 77:1991;472-480.
5. Herodin F., Mestries J.C., Janodet D., et al. Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons. Blood. 80:1992;688-695.
6. Leonard J.P., Quinto C.M., Kozitza M.K., et al. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood. 83:1994;1499-1506.
7. Morstyn G., Foote M., Perkins D., et al. The clinical utility of granulocyte colony-stimulating factor: Early achievements and future promise. Stem Cells. 12:(Suppl. 1):1994;213-227.
8. Neta R., Oppenheim J.J. Cytokines in therapy of radiation injury. Blood. 72:1988;1093-1095.
9. Schuening F.G., Appelbaum F.R., Deeg H.J., et al. Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood. 81:1993;20-26.
10. Schuening F.G., Storb R., Goehle S., et al. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood. 74:1989;1308-1313.
11. Mac Vittie T.J., Monroy R.L., Patchen M.L., et al. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol. 57:1990;723-736.
12. Tanikawa S., Nose M., Aoki Y., et al. Effects of recombinant granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice. Blood. 76:1990;445-449.
13. Patchen M.L., MacVittie T.J., Souza L.M. Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hemopoietic reconstitution and increase survival. Int J Radiat Oncol Biol Phys. 22:1992;773-779.
14. Galmiche M.C., Vogel C.A., Delaloye A.B., et al. Combined effects of interleukin-3 and interleukin-11 on hematopoiesis in irradiated mice. Exp Hematol. 24:1996;1298-1306.
15. Weisdorf D., Katsanis E., Verfaillie C., et al. Interleukin-1 alpha administered after autologous transplantation a phase I/II clinical trial . Blood. 84:1994;2044-2049.
16. Vial T., Descotes J. Clinical toxicity of cytokines used as haemopoietic growth factors. Drug Saf. 13:1995;371-406.
17. Gillio A.P., Bonilla M.A., Potter G.K., et al. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates. Transplant Proc. 19:1987;153-156.
18. Lindemann A., Herrmann F., Oster W., et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood. 74:1989;2644.
19. Antich Rojas J.L., Balaguer Munoz H., Girona Llobera E., et al. Transient thrombocytopenia after the administration of granulocyte colony-stimulating factor in a patient with acute agranulocytosis. Sangre. 38:1993;155.
20. Molineux G., Hartley C.A., McElroy P., et al. Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation. Blood. 88:1996;1509-1514.
21. Farese A.M., Hunt P., Grab L.B., et al. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest. 97:1996;2145-2151.
22. Wendling F., Marakovsky E., Debili N., et al. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369:1994;571-574.
23. de Sauvage F., Hass P.E., Spencer S.D., et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 369:1994;533-538.
24. Lok K., Kaushansky K., Holly R.D., et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 369:1994;565-568.
25. Bartley T.D., Bogenberger J., Hunt P., et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 77:1994;1117-1124.
26. Kuter D.J., Beeler D.L., Rosenberg R.D. The purification of megapoietin: A physiological regular of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA. 91:1994;11104-11108.
27. Hunt P., Li Y.S., Nichol J.L., et al. Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood. 86:1995;540-547.
28. Kato T., Ogami K., Shimada Y., et al. Purification and characterization of thrombopoietin. J Biochem. 118:1995;229-236.
29. Eaton D.L., de Sauvage F.J. Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol. 25:1997;1-7.
30. Hokom M.M., Lacey D., Kinstler O.B., et al. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood. 86:1995;4486-4492.
31. Kaushansky K., Lin N., Grossmann A., et al. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol. 24:1996;265-269.
32. Grossmann A., Lenox J., Ren H.P., et al. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp Hematol. 24:1996;1238-1246.
33. Grossmann A., Lenox J., Deisher T.A., et al. Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice. Blood. 88:1996;3363-3370.
34. Thomas G.R., Thibodeaux H., Errett C.J., et al. In vivo biological effects of various forms of thrombopoietin in a murine model of transient pancytopenia. Stem Cells. 14:1996;246-255.
35. Neelis K.J., Qingliang L., Thomas G.R., et al. Prevention of thrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietic stimulation and iron depletion. Blood. 90:1997;58-63.
36. Neelis K.J., Dubbelman Y.D., Qingliang L., et al. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp Hematol. 25:1997;1084-1093.
37. Neelis K.J., Hartong S.C., Egeland T., et al. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys. Blood. 90:1997;2565-2573.
38. Shibuya K., Akahori H., Takahashi K., et al. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice. Blood. 91:1998;37-45.
39. Kaushansky K., Broudy V.C., Grossmann A., et al. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest. 96:1995;1683-1687.
40. Young J.C., Bruno E., Luens K.M., et al. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin-primitive progenitor cells. Blood. 88:1996;1619-1631.
41. Sitnicka E., Lin N., Priestley G.V., et al. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood. 87:1996;4998-5005.
42. Kobayashi M., Laver J.H., Kato T., et al. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood. 88:1996;429-436.
43. Ramsfjell V., Borge O.J., Cui L., et al. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: Distinct and key interactions with the ligands for ckit and flt3, and inhibitory effects of TGFbeta and TNF-alpha. J Immunol. 158:1997;5169-5177.
44. Tanimukai S., Kimura T., Sakabe H., et al. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Exp Hematol. 25:1997;1025-1033.
45. Fanucchi M., Glaspy J., Crawford J., et al. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. N Engl J Med. 336:1997;404-409.
46. Basser R.L., Rasko J.E., Clarke K., et al. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet. 348:1996;1279-1281.
47. Basser R.L., Rasko J.E., Clarke K., et al. Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood. 89:1997;3118-3128.
48. O'Malley C.J., Rasko J.E., Basser R.L., et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood. 88:1996;3288-3298.
49. Neelis K.J., Visser T.P., Dimjati W., et al. A single dose of thrombopoietin early after myelosuppressive total body irradiation prevents pancytopenia by promoting short-term multilineage repopulating cells at the expense of a more immature cell population. Blood. 92:1998;1586-1597.
50. Gregory C.J. Erythropoietin sensitivity as a differentiation marker in the hemopoietic system: studies of three erythropoietic colony responses in culture. J Cell Physiol. 89:1976;289-301.
51. Humphries R.K., Eaves A.C., Eaves C.J. Self-renewal of hemopoietic stem cells during mixed colony formation in vitro. Proc Natl Acad Sci USA. 78:1981;3629-3633.
52. Burstein S., Adamson J., Thorning D. Characteristics of murine megakaryocytic colonies in vitro. Blood. 54:1979;169-179.
53. Boggs D.R. The total marrow mass of the mouse: A simplified method of measurement. Am J Hematol. 16:1984;277-286.
54. Jiang S., Levine J.D., Fu Y., et al. Cytokine production by primary bone marrow megakaryocytes. Blood. 84:1994;4151-4156.
55. Wickenhauser C., Lorenzen J., Thiele J., et al. Secretion of cytokines (interleukins-1 alpha, -3, -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes. Blood. 85:1995;685-691.
56. Fibbe W.E., Heemskerk D.P., Laterveer L., et al. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood. 86:1995;3308-3313.
57. Neelis K.J., Dubbelman Y.D., Wognum A.W., et al. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys. Exp Hematol. 25:1997;1094-1103.
58. Sureda A., Valls A., Kadar E., et al. A single dose of granulocyte colony-stimulating factor modifies radiation-induced death in B6D2F1 mice. Exp Hematol. 21:1993;1605-1607.
59. Ploemacher R.E., van Os R., van Beurden C.A., et al. Murine haemopoietic stem cells with long-term engraftment and marrow repopulating ability are more resistant to gamma-radiation than are spleen colony forming cells. Int J Radiat Biol. 61:1992;489-499.
60. Farese A.M., Hunt P., Boone T., et al. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood. 86:1995;54-59.
61. Kabaya K., Akahori H., Shibuya K., et al. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice. Stem Cells. 14:1996;651-660.
62. Harker L.A., Hunt P., Marzec U.M., et al. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood. 87:1996;1833-1844.
63. Andrews R.G., Winkler A., Myerson D., et al. Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons. Stem Cells. 14:1996;661-677.
64. Ulich T.R., del Castillo J., Senaldi G., et al. Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood. 87:1996;5006-5015.
65. Arnold J.T., Daw N.C., Stenberg P.E., et al. A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization. Blood. 89:1997;823-833.
66. Daw N.C., Arnold J.T., Abushullaih B.A., et al. A single intravenous dose of murine megakaryocyte growth and development factor potently stimulates platelet production, challenging the necessity for daily administration. Blood. 91:1998;466-474.
67. Banu N., Wang J.F., Deng B., et al. Modulation of megakaryocytopoiesis by thrombopoietin: The c-Mpl ligand. Blood. 86:1995;1331-1338.
68. Zeigler F.C., de Sauvage F., Widmer H.R., et al. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood. 84:1994;4045-4052.
69. Patchen M.L., MacVittie T.J., Jackson W.E. Postirradiation glucan administration enhances the radioprotective effects of WR-2721. Radiat Res. 117:1989;59-69.
70. Neta R., Douches S.D., Oppenheim J.J. Radioprotection by interleukin-1. Goldstein G., Bach J.F., Wigzal H., et al. Immunoregulation by characterized polypeptides. UCLA Symposia on Molecular and Cellular Biology. 1986;429 Liss, New York.
71. Wagemaker G. Heterogeneity of radiation sensitivity of hematopoietic stem cell subsets. Stem Cells. 13:1995;257-260.
72. MacManus M., Lamborn K., Khan W., et al. Radiotherapy-associated neutropenia and thrombocytopenia: Analysis of risk factors and development of predictive model. Blood. 90:1997;2303-2309.
73. Knox S.J., Varghese A., Khan W., et al. A prospective study of radiation therapy-associated thrombocytopenia. Blood. 90:1997;4237-4238.